Joseph Bratica
Comptroller/Controller/Auditor bij SAREPTA THERAPEUTICS, INC.
Profiel
Joseph Bratica is Vice President & Controller voor Sarepta Therapeutics, Inc. Daarvoor bekleedde hij de functie van Accounting Manager bij Creative Biomolecules, Inc. en Vice President-Finance & Controller bij ARIAD Pharmaceuticals, Inc. Hij behaalde een bachelordiploma aan de Suffolk University.
Actieve functies van Joseph Bratica
Bedrijven | Functie | Begin |
---|---|---|
SAREPTA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-03-2017 |
Eerdere bekende functies van Joseph Bratica
Bedrijven | Functie | Einde |
---|---|---|
ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-01-2016 |
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Comptroller/Controller/Auditor | 01-01-1994 |
Opleiding van Joseph Bratica
Suffolk University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |